Kaiser J, Yassin M, Prakash S, Safi N, Agami M, Lauw S, Ostrozhenkova E, Bacher A, Rohdich F, Eisenreich W, Safi J, Golan-Goldhirsh A
Lehrstuhl für Organische Chemie und Biochemie, Technische Universität München, Lichtenbergstr. 4, D-85747 Garching, Germany.
Phytomedicine. 2007 Apr;14(4):242-9. doi: 10.1016/j.phymed.2006.12.018. Epub 2007 Feb 12.
The recently discovered non-mevalonate pathway of isoprenoid biosynthesis serves as the unique source of terpenoids in numerous pathogenic eubacteria and in apicoplast-type protozoa, most notably Plasmodium, but is absent in mammalian cells. It is therefore an attractive target for anti-infective chemotherapy. The first committed step of the non-mevalonate pathway is catalyzed by 2C-methyl-D-erythritol 4-phosphate synthase (IspC). Using photometric and NMR spectroscopic assays, we screened extracts of Mediterranean plants for inhibitors of the enzyme. Strongest inhibitory activity was found in leaf extracts of Cercis siliquastrum.
最近发现的类异戊二烯生物合成非甲羟戊酸途径是许多致病性真细菌和顶质体类型原生动物(最显著的是疟原虫)中萜类化合物的唯一来源,但在哺乳动物细胞中不存在。因此,它是抗感染化疗的一个有吸引力的靶点。非甲羟戊酸途径的第一个关键步骤由2C-甲基-D-赤藓糖醇4-磷酸合酶(IspC)催化。我们使用光度法和核磁共振光谱分析法,筛选了地中海植物提取物中该酶的抑制剂。在紫荆叶提取物中发现了最强抑制活性。